am 251 and jte 907

am 251 has been researched along with jte 907 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A1
Altun, A; Bagcivan, I; Durmus, N; Gursoy, S; Ozdemir, E; Yildirim, K1
Bianchi, PC; Costa-Ferreira, W; Crestani, CC; Cruz, FC; Gomes-de-Souza, L; Tomeo, RA1

Other Studies

3 other study(ies) available for am 251 and jte 907

ArticleYear
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism

2011
Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.
    The journal of physiological sciences : JPS, 2015, Volume: 65, Issue:5

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dioxoles; Dose-Response Relationship, Drug; Drug Tolerance; Male; Morphine; Nociception; Pain Threshold; Piperidines; Pyrazoles; Quinolones; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2015
CB
    Progress in neuro-psychopharmacology & biological psychiatry, 2021, 08-30, Volume: 110

    Topics: Animals; Anxiety; Cannabinoid Receptor Antagonists; Dioxoles; Endocannabinoids; Gene Expression; Male; Models, Neurological; Piperidines; Pyrazoles; Quinolones; Rats; Rats, Wistar; Restraint, Physical; Septal Nuclei; Stress, Psychological; Synaptic Transmission

2021
chemdatabank.com